Top Anti-malaria’s Injection Manufacturer And Supplier

By Author: Tivesa Singh
Total Articles: 2
Comment this article

In 2022, there were an estimated 249 million malaria cases reported globally and nearly 608000 people died due to malaria in around 85 countries. However, in 2022 the WHO African Region has reported the highest percentage of malaria cases around 94% and 95% of deaths. Notably children under 5 years of age have accounted about 78% of all malaria deaths in the region. Apart from this, in the African Region pregnant women are also severely affected by malaria, with an estimated 12.7 million malaria infection during pregnancy.

Here's the breakdown of four African countries data.

In Nigeria alone 26.8% and around 31% of all malaria cases and deaths were reported in 2022. The Democratic Republic of the Congo (12%), Uganda (5%) and Mozambique (4%) accounted for almost half of all cases globally.
Now, you might be wondering, why we are mentioning global malaria case data and highlighting the most affected countries, such as the Nigeria, Zambia, Kenya, Uganda, Namibia, and South Africa. Sanjar Pharma is committed towards combating the malaria cases with our high-quality Anti-Malarials medicine. Our professional team ...
... is dedicated on improving malaria outcomes, particularly in the WHO South Africa regions, ensuring that these severely affected regions benefit from our economically high-quality Anti-Malarials injections such as, Injection Arteether, Injection Artemether and Injection Quinine Dihydrochloride.
Sanjar Pharma’s Anti-Malarials injections (Arteether, Artemether and Quinine Dihydrochloride), are affordable and effective in preventing malarias in patients.

Comprehensive guide to our Anti-malarial Injections
Arteether injections are used to treat severe malaria, especially caused by Plasmodium falciparum, which is known for its life-threatening infections. This injection is also used with the combination of lumefantrine to treat severe malaria caused by p. falciparum and unidentified Plasmodium species. However, Arteether injection intramuscular administration is beneficial when oral medication is feasible due to complication like vomiting, thus making it safer option for severe cases.

Artemether injection are used in combination with lumefantrine for acute uncomplicated malaria caused by plasmodium falciparum. It works by rapidly killing malaria parasites in the blood stage. Once injected, it is converted into its active form, dihydroartemisinin (DHA), which targets the parasite’s ability to digest hemoglobin. However, artemether injections act quickly, reducing the parasite load within 48 hours and help prevent life-threatening complications such as cerebral malaria, organ failure and severe anemia.

Quinine Dihydrochloride specifically targets the blood-stage parasites responsible for the clinical symptoms of malaria. It works by interfering with the parasite’s ability to break down hemoglobin in red blood cell, which is essential for the parasite’s survival. It is primarily used in critical condition where parasite load can lead to cerebral complications, organs failure, or severe anemia. This injection is often administered intravenously or intramuscularly. Quinine Dihydrochloride can also be combined with other antimalarial drugs for better and enhanced efficacy.

Direct Access to our High-Quality Anti-Malarial Injections
The use of effective anti-malarial injections like Artemether, Arteether, and Quinine Dihydrochloride is crucial for treatment and prevention in heavily malaria impacted Countries such as Zambia, Kenya, Nigeria, Uganda, Namibia and South Africa. Sanjar Pharma’s injection are specifically developed to target the malaria particularly caused by Plasmodium falciparum.

Sanjar Pharma is proud to announce that now we provide direct access to our high-quality anti-malarial injections without the involvement of third parties.

This approach allows customers from the countries like Zambia, Kenya, Nigeria, Uganda, Namibia and South Africa to place bulk orders directly with us. Sanjar Pharma ensures faster delivery, competitive pricing and reliable products. Customers from these countries can now place bulk orders directly with us, benefitting from our offerings that start as low as $200 per bulk order ensuring simplified procurement process for clinics and hospitals, guaranteeing timely delivery of effective Anti-Malarial medications.

For any inquiries or to place an order with us, please reach out to our team and experience our seamless process, timely delivery of effective anti-malarial medications.
Email us: marketing@sanjarpharma.com
Whatsapp us: +916352986603
Call us: 02772-245249

Who we are:

Sanjar pharma is a leading company incorporated in the year 2014, headquartered in Himatnagar (Gujarat). We are rapidly growing pharmaceutical company expertise in injection manufacturing including Dry powder injections, Liquid Vial, Ampoule Injection, PFS injection, and suspension injection as well ear and eye drops. Our products reach patients and healthcare providers in various regions, showcasing our dedication to global health.